Companies: 10,795·Total market cap: $144.5T
Spectral AI, Inc.

Spectral AI, Inc.

MDAINASDAQHealthcare● Active
$1.85
$-0.04(-2.12%)
Market Cap$58874372
P/E Ratio
52W High$3.21
52W Low$1.18

Spectral AI, Inc. (MDAI) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

mdai · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Spectral AI, Inc. (MDAI) measures how much investors pay for each dollar of the company's trailing earnings. MDAI's current PE ratio of N/A is calculated by dividing its stock price of $1.85 by its TTM earnings per share of -$0.45.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2027 est. EPS $-0.54
Based on 2 analysts
EPS (TTM)
-$0.45
TTM · diluted EPS
PEG Ratio
0.05
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Spectral AI, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2020 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Spectral AI, Inc.
Spectral AI, Inc.You
MDAI
$59MN/A-$0.45
Coeptis Therapeutics, Inc.
Coeptis Therapeutics, Inc.
COEP
$58MN/A-$2.81
Cytosorbents Corporation
Cytosorbents Corporation
CTSO
$26MN/A-$0.13
electroCore, Inc.
electroCore, Inc.
ECOR
$80MN/A-$1.65
Equillium, Inc.
Equillium, Inc.
EQ
$98MN/A-$0.24
IceCure Medical Ltd
IceCure Medical Ltd
ICCM
$8MN/A-$7.10
Century Therapeutics, Inc.
Century Therapeutics, Inc.
IPSC
$184MN/A-$0.11

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 6 of 6 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-0.29
2024-12-31
FY2024
$-0.85
2023-12-31
FY2023
$-1.48
2022-12-31
FY2022
$-0.16
2021-12-31
FY2021
$-0.22
2020-12-31
FY2020
$0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Spectral AI, Inc. (MDAI) measures how much investors pay for each dollar of the company's trailing earnings. MDAI's current PE ratio of N/A is calculated by dividing its stock price of $1.85 by its TTM earnings per share of -$0.45.

PE Ratio = Stock Price ÷ EPS (TTM)
= $1.85 ÷ -$0.45 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

MDAI pe ratio · 6 questions

MDAI's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.85 and TTM EPS of -$0.45. Data sourced from Financial Modeling Prep via MDAI's SEC 10-K and 10-Q filings.

MDAI PE ratioWhat is MDAI PE ratioCurrent PE ratio of MDAIMDAI PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Spectral AI, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09